Relationship between the expression of Geminin, CDK4 and biological behaviors of colorectal carcinoma

doi:10.3877/cma.j.issn.1674-3946.2018.04.024

Abstract

Abstract:

Objective

To study the relationship between the expression of Geminin and cyclin dependent kinase 4 (CDK4) and the biological behavior and prognosis of colorectal carcinoma.

Methods

50 cases specimen of colorectal carcinoma and complete follow-up data were collected from May 2011 to May 2014. SP immunochemical method was performed to detect the expression of Geminin and CDK4 in 50 cases of colorectal carcinoma, 20 cases of colorectal adenomas and 20 cases of normal colorectal tissues. SPSS 13.0 software was used for statistical analysis. Chi square test and Spearman correlation analysis were used to analyze the data. P<0.05 was statistically significant for the difference.

Results

The positive rates of Geminin and CDK4 in colorectal carcinoma tissues, colorectal adenomas and normal colorectal mucosa tissues group were gradually decreased, and there were significant difference between each group (P<0.05). The expressions of Geminin and CDK4 were closely related to the degree of differentiation, lymph node metastasis, Duke’s stages and the deepness of invasion (P<0.05). The expression of Geminin was positively correlated with CDK4 (P<0.05). The 3 years survival rates after operation in positive expression groups of Geminin (23.8%) and CDK4 (22.5%) were significantly lower than those in negative expression groups (60.0%).

Conclusion

The abnormal expressions of Geminin and CDK4 may participate in the occurrence and development of colorectal carcinorma. The detection of both may be used as an important reference index for clinical judgement of malignancy, metastasis and prognosis of colorectal carcinoma.

Key words: Colorectal Neoplasms, Geminin, Cyclin-Dependent Kinase 4, Immunohistochemistry

Xing Dong, Jing Wang, Bo Yu. Relationship between the expression of Geminin, CDK4 and biological behaviors of colorectal carcinoma[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2018, 12(04): 346-348.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhpwkssxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-3946.2018.04.024

https://zhpwkssxzz.cma-cmc.com.cn/EN/Y2018/V12/I04/346

Figures/Tables 3

References 13

[1]	Suchyta M, Miotto B, McGarry TJ. An inactive geminin mutant that binds cdt1[J]. Genes (Basel)，2015,6(2):252-266.
[2]	Zhang L, Cai M, Gong Z, et al. Geminin facilitates FoxO3 deacetylation to promote breast cancer cell metastasis[J]. J Clin Invest，2017,127(6):2159-2175.
[3]	Liu M, Liu H, Chen J. Mechanisms of the CDK4/6 inhibitor palbociclib (PD 0332991) and its future application in cancer treatment (Review)[J]. Oncol Rep，2018 ,39(3):901-911.
[4]	Lu F, Lan R, Zhang H, et al. Geminin is partially localized to the centrosome and plays a role in proper centrosome duplication[J]. Biol Cell，2009,101(5):273-285.
[5]	田薇，章建国，刘益飞. Geminin在胃癌组织中的表达及临床意义[J]. 江苏医药，2017,43(15):1093-1095.
[6]	Hernández－Pérez S, Cabrera E, Salido E, et al. DUB3 and USP7 de－ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer[J]. Oncogene，2017,36(33):4817-4817.
[7]	Ikemura S, Aramaki N, Fujii S, et al. Changes in the tumor microenvironment during lymphatic metastasis of lung squamous cell carcinoma[J]. Cancer Sci，2017,108(1):136-142.
[8]	Slawny N, O'Shea KS. Geminin promotes an epithelial－to－mesenchymal transition in an embryonic stem cell model of gastrulation[J]. Stem cells Dev，2013,22(8):1177-1189.
[9]	Ananthula S, Sinha A, El Gassim M, et al. Geminin overexpression－dependent recruitment and crosstalk with mesenchymal stem cells enhance aggressiveness in triple negative breast cancers[J]. Oncotarget, 2016,7(15):20869-20889.
[10]	Patel P, Asbach B, Shteyn E，et al.Brk /Protein tyrosine kinase 6 phosphorylates p27KIPI，regulating the activity of CyclinD－Cyclin－ dependent kinase 4[J]. Mol Cell Biol，2015,35(9):1506-1522.
[11]	Dickson MA. Molecular pathways: CDK4 inhibitors for cancer therapy[J]．Clin Cancer Res，2014,20(13):3379-3383.
[12]	田薇，章建国，刘益飞，等. CDK4和Geminin在胶质瘤中的表达及其与预后的关系[J]. 南京医科大学学报(自然科学版)，2017,37(6):709-713.
[13]	Xu G, Li JY. CDK4, CDK6, cyclin D1, p16(INK4a) and EGFR expression in glioblastoma with a primitive neuronal component[J]. J Neurooncol，2018 ,136(3):445-452.

病理因素		例数	Geminin			CDK4
病理因素		例数	＋	χ²值	P值	＋	χ²值	P值
性别		?	?	?	?	?	?	?
?	男	32	28	0.810	>0.05	25	0.195	>0.05
?	女	18	14	0.810	>0.05	15	0.195	>0.05
年龄(岁)		?	?	?	?	?	?	?
?	≤40	18	13	2.903	>0.05	16	1.389	>0.05
?	>40	32	29	2.903	>0.05	24	1.389	>0.05
肿瘤大小		?	?	?	?	?	?	?
?	≤3 cm	35	30	0.255	>0.05	30	2.381	>0.05
?	>3 cm	15	12	0.255	>0.05	10	2.381	>0.05
分化程度		?	?	?	?	?	?	?
?	高中分化	27	20	4.303	<0.05	18	6.522	<0.05
?	低分化	23	22	4.303	<0.05	22	6.522	<0.05
浸润深度		?	?	?	?	?	?	?
?	粘膜或浅肌层	20	14	4.861	<0.05	13	4.688	<0.05
?	深肌层或全层	30	28	4.861	<0.05	27	4.688	<0.05
淋巴结转移		?	?	?	?	?	?	?
?	有	31	29	5.534	<0.05	28	5.433	<0.05
?	无	19	13	5.534	<0.05	12	5.433	<0.05
肿瘤分期		?	?	?	?	?	?	?
?	A期	6	2	13.829	<0.01	2	10.016	<0.01
?	B期	21	18			17
?	C期	23	22			21

病理因素		例数	Geminin			CDK4
病理因素		例数	＋	χ²值	P值	＋	χ²值	P值
性别		?	?	?	?	?	?	?
?	男	32	28	0.810	>0.05	25	0.195	>0.05
?	女	18	14	0.810	>0.05	15	0.195	>0.05
年龄(岁)		?	?	?	?	?	?	?
?	≤40	18	13	2.903	>0.05	16	1.389	>0.05
?	>40	32	29	2.903	>0.05	24	1.389	>0.05
肿瘤大小		?	?	?	?	?	?	?
?	≤3 cm	35	30	0.255	>0.05	30	2.381	>0.05
?	>3 cm	15	12	0.255	>0.05	10	2.381	>0.05
分化程度		?	?	?	?	?	?	?
?	高中分化	27	20	4.303	<0.05	18	6.522	<0.05
?	低分化	23	22	4.303	<0.05	22	6.522	<0.05
浸润深度		?	?	?	?	?	?	?
?	粘膜或浅肌层	20	14	4.861	<0.05	13	4.688	<0.05
?	深肌层或全层	30	28	4.861	<0.05	27	4.688	<0.05
淋巴结转移		?	?	?	?	?	?	?
?	有	31	29	5.534	<0.05	28	5.433	<0.05
?	无	19	13	5.534	<0.05	12	5.433	<0.05
肿瘤分期		?	?	?	?	?	?	?
?	A期	6	2	13.829	<0.01	2	10.016	<0.01
?	B期	21	18			17
?	C期	23	22			21

[1]	Qingshan Luo, Haitao Mei, Jialing Hao, Jinfeng Cai, Runkai Zhou, Yugang Wen. Connexin 43 inhibiting the proliferation of colorectal cancer by regulating the cell cycle [J]. Chinese Archives of General Surgery(Electronic Edition), 2024, 18(05): 344-349.
[2]	Yinan Xu. Curative effect of different operation methods in the treatment of obstructive left colorectal cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(01): 72-75.
[3]	Ningning Hu, Yanrong Zhao, Dong Wang, Shengliang Wang, Yuan Guo. The correlation study between the expression of FMNL3 and prognosis in hepatocellular carcinoma liver transplant recipients [J]. Chinese Journal of Transplantation(Electronic Edition), 2024, 18(05): 283-288.
[4]	Qinliang Si, Shilong Bi, Huixiao Jiao, Shizhao Li, Zheyu Chen, Yudong Wu. Two cases of dedifferentiated liposarcoma of spermatic cord and literature review [J]. Chinese Journal of Endourology(Electronic Edition), 2024, 18(06): 585-590.
[5]	Jiagang Han, Zhenjun Wang. The treatment strategies for obstructive left-sided colon cancer [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(06): 450-458.
[6]	Xuanhao Liang, Xiaorong Li, Liang Li, Changwei Lin. Efficacy and prognosis of colonic stenting combined with neoadjuvant chemotherapy for acute obstructive colorectal cancer： a Meta-analysis [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(06): 472-482.
[7]	Hongxia Yan, Xiaojuan Wang, Yixun Zhang. The effect of type 2 diabetes on tumor markers， clinicopathology and prognosis in patients with colorectal cancer [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(06): 483-487.
[8]	Lei Zhao, Wenzhi Liu, Feng Lin, Jian Yu, Mingjun Sun, Yougang Cui, Xu Zhang, Yupeng Yi, Baosheng Yu, Ning Feng. The study on the effects of deep hyperthermia in improving side effects of adjuvant chemotherapy and quality of life in the patients after colorectal cancer surgery [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(06): 488-493.
[9]	Haiyang Huang, Yonglong Kuang, Jiasheng Chen. Analysis of 30 cases of natural orifice specimen extraction surgery for colorectal neoplasm in primary hospital [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(06): 510-518.
[10]	Zeyun Zhao, Jiannan Li, Min Wang. Research progress of neutrophil extracellular traps in colorectal cancer [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(06): 524-528.
[11]	Jiaqi Ren, Dechang Diao, Ziyan He, Xueyang Zhang, Xin Tang, Wenjuan Li, Hongming Li, Xinquan Lu, Xiaojiang Yi. Omental fusion line-guided splenic flexure mobilization technique in radical left hemicolon for colon cancer [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(05): 362-367.
[12]	Di Zhang, Chunxia Wang, Xuedong Zhang, Faxin Li, Xiwen Pang, Yifeng Chen, Weisheng Zhang, Tao Wang. Short-term clinical outcomes of laparoscopic versus open surgery after self-expansion metallic stent placement for obstructive left-sided colorectal cancer [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(05): 375-380.
[13]	Weilin Zhang, Zhexue Wang, Junge Bai, Zhongcheng Huang, Zhigang Xiao. Exploiting the TCGA database to establish a nomogram prognostic model of miRNAs associated with colorectal cancer [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(05): 381-388.
[14]	Weiwei Zhang, Qi Chen, Heyu Weng, Liang Huang. Preliminary study on prediction of lymph node metastasis of T1 colorectal cancer by random forest model [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(05): 389-393.
[15]	Ruiyi Tan. Current advances and developments in diagnosis and treatment of small cell osteosarcoma [J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(08): 781-784.

Please choose a citation manager

Content to export